Dolores J. Schendel. Is it time to abandon RHAMM/HMMR as a candidate antigen for immunotherapy of acute myeloid leukemia?. haematol [Internet]. 2012Oct.9 [cited 2024Apr.26];97(10):1454-5. Available from: https://haematologica.org/article/view/6428